U.S. Plans to Spend Billions to Increase Covid Vaccine Supplies
The White House, under pressure from activists to increase the supply of coronavirus vaccines to poor nations, is prepared to invest billions of dollars to expand U.S. manufacturing capacity, with the goal of producing at least one billion doses a year beginning in the second half of 2022, two top advisers to President Biden said in an interview on Tuesday.
The investment is the first step in a new plan, to be announced on Wednesday, for the government to partner with industry to address immediate vaccine needs overseas and domestically and to prepare for future pandemics, said Dr. David Kessler, who oversees vaccine distribution for the administration, and Jeff Zients, Mr. Bidens coronavirus response coordinator.
This is about assuring expanded capacity against Covid variants and also preparing for the next pandemic, Dr. Kessler said. The goal, in the case of a future pandemic, a future virus, is to have vaccine capability within six to nine months of identification of that pandemic pathogen, and to have enough vaccines for all Americans.
The White House, under pressure from activists to increase the supply of coronavirus vaccines to poor nations, is prepared to invest billions of dollars to expand U.S. manufacturing capacity, with the goal of producing at least one billion doses a year beginning in the second half of 2022, two top advisers to President Biden said in an interview on Tuesday.
President Biden has been pressed to do more to scale up global vaccine manufacturing capacity.© Stefani Reynolds for The New York Times President Biden has been pressed to do more to scale up global vaccine manufacturing capacity.
The investment is the first step in a new plan, to be announced on Wednesday, for the government to partner with industry to address immediate vaccine needs overseas and domestically and to prepare for future pandemics, said Dr. David Kessler, who oversees vaccine distribution for the administration, and Jeff Zients, Mr. Bidens coronavirus response coordinator.
This is about assuring expanded capacity against Covid variants and also preparing for the next pandemic, Dr. Kessler said. The goal, in the case of a future pandemic, a future virus, is to have vaccine capability within six to nine months of identification of that pandemic pathogen, and to have enough vaccines for all Americans.
Sign up for The Morning newsletter from The New York Times
The idea for the new public-private partnership is still in its early stages, and the price tag is uncertain. Dr. Kessler, who has been working on the proposal for months, estimated it at several billion. The money has been set aside as part of the American Rescue Plan, the $1.9 trillion pandemic relief package that Mr. Biden signed into law in March.
https://www.msn.com/en-us/news/us/us-plans-to-spend-billions-to-increase-covid-vaccine-supplies/ar-AAQNU17